1. Introduction {#sec0005}
===============

Ferrets are an outbred population widely used to study influenza virus infection ([@bib0345], [@bib0355], [@bib0360], [@bib0350]) as well as a range of other diseases, including SARS-coronavirus (CoV) (reviewed in ([@bib0265])) and henipaviruses, such as infection with Hendra virus and Nipah virus ([@bib0030], [@bib0230], [@bib0235], [@bib0090]). The anatomical and physiological similarity between human and ferret lungs also enables ferrets to be used as a model to study lung carcinomas (reviewed in [@bib0020]). Recently, absence of the cystic fibrosis transmembrane conductance regulator (CFTR) was associated with spontaneous disease induction in the lung and pancreas in ferrets, showing similar pathology to that of cystic fibrosis in humans ([@bib0295], reviewed in [@bib0145]). The broad utility of this model is highlighted by the use of ferrets to study pneumococcal transmission, reproductive biology and human fetal brain development (reviewed in [@bib0020]).

While the ferret is a good model for human respiratory virus infections, reagents to identify ferret leukocytes and immune mediators are limited. Studies have identified cross-reactive antibodies that recognize populations of ferret leukocytes, such as CD8, CD11β, CD44 and CD25, and cytokines IFNγ, TNFα, IL4 and IL8 ([@bib0275], [@bib0170], [@bib0250]). Cloning and sequencing of ferret cytokine genes have enabled molecular approaches targeting the corresponding mRNAs ([@bib0330], [@bib0060], [@bib0205], [@bib0225], [@bib0255]). Expression of cytokine and chemokine genes has been assessed in *ex vivo* samples following infection of naïve or vaccinated ferrets with influenza virus or SARS-CoV by microarray analysis ([@bib0040], [@bib0080], [@bib0270]). Cytokine and chemokine gene profiles have also been assessed *ex vivo* and in *in vitro* epithelial cultures using SYBR green real time RT-PCR assays ([@bib0300], [@bib0040], [@bib0060], [@bib0065], [@bib0305], [@bib0150], [@bib0080], [@bib0115], [@bib0155], [@bib0270], [@bib0135], [@bib0185], [@bib0190], [@bib0250], [@bib0125], [@bib0160], [@bib0195], [@bib0025], [@bib0340]). TaqMan chemistry incorporates target-specific fluorescent labeled probes enabling multiple genes can be assessed in a single real time PCR reaction ([@bib0100]). To date, TaqMan real time RT-PCR assays have only been developed for a smaller number of ferret-specific gene targets ([@bib0210], [@bib0290]).

To enable a broader characterization of the immune response in the ferret model, we developed a panel of TaqMan assays to detect mRNA of fifteen ferret cytokines, chemokines and immune mediators (IFNα, IFNβ, IFNγ, IL1α, IL1β, IL2, IL4, IL6, IL8, IL10, IL12p40, IL17, granzyme A, MCP-1, TNFα) and four housekeeping genes (ATF4, GAPDH, L32 and HPRT). The cytokine and chemokine profile induced by stimulation of ferret leukocytes with mitogens or influenza virus was also assessed to investigate the relevance of the ferret immune response to human infection studies.

2. Materials and methods {#sec0010}
========================

2.1. Design of ferret cytokine and housekeeping gene primers and probes {#sec0015}
-----------------------------------------------------------------------

Sequences for cytokine, chemokine and housekeeping genes of multiple species were obtained from Genbank (<http://www.ncbi.nlm.nih.gov/genbank>) and aligned. Regions of conservation were identified and primers were designed using PrimerSelect (DNASTAR Lasergene8, Madison, USA) or PrimerExpress (Applied Biosystems, California, USA) to amplify the region from ferret cDNA. Cloned genes were sequenced and TaqMan real time PCR primers and probes designed using PrimerExpress. All oligonucleotide primers and probes used in this study, including those previously published, are listed in [Table 1](#tbl0005){ref-type="table"} . Primers for IFNα were designed to amplify multiple subtypes (1--12) ([@bib0075], [@bib0120]).Table 1Oligonucleotide primer and probe sequences used in this study. Primers and probes developed for the TaqMan real time RT-PCR assay in this study are highlighted in bold italics. Primers (and probes) from other published real time RT-PCR studies, TaqMan and SYBR Green, are indicated. Primers used to clone inserts for plasmid controls are also indicated, and referenced as appropriate.Gene targetForward primer 5′ → 3′Reverse primer 5′ → 3′ProbeUseReference***IL1α****CTGAAACCTCAAAGACATCTCATCTT****GCTGGCTGCCACCATCA****FAM-CCTTCAAGGAGGATGTG- MGBNFQ****TaqMan***This studyIL1αTTCTCTGAATCAGAAATCCTTCTATGATCTCTTACAAAGAGAGTAAACATTCATTTGGCloningThis study***IL1β****CCTGGTGCTGTATAACTCGTATGAG****TTGGTTCACACTAGTTCCGTTGA****VIC-TCGGGCGCTCCAC- MGBNFQ****TaqMan***Reverse primer matches ([@bib0080], [@bib0270])IL1βAGATGAAGTGCTGCTTCCAAGACGTGCTGATGTACCAGTTGGGAAACloningThis studyIL1βGGACTGCAAATTCCAGGACATAATTGGTTCACACTAGTTCCGTTGASYBR green[@bib0080] and [@bib0270]***IL2****GTTAAAAATTATGAGAGCCCCAGGA****TTGAGTTCTTCTGCTAGACATTGAAGA****FAM-CTACATGCCCAAGAAG-MGBNFQ****TaqMan***This studyIL2GCAACTCTTGTCTTGCATCGTACTCAAGTCAGTGTTGAGAAGATGCCloningThis studyIL2TGCTGCTGGACTTACAGTTGCTCTCAATTCTGTGGCCTTCTTGGGCATSYBR green[@bib0300]***IL4****CCAACAGATTGCTCAGAGGACTT****CACCGAACAGGTCATGTTTGC****6FAM-CAGGAACCTCAGGAACAT-MGBNFQ****TaqMan assay***This studyIL4GATCTATTAATGGGTCTCACCTCCAGCTTCAATGCCTGTAGTATTTCTGCloningThis studyIL4CGTTGAACATCCTCACAGCGAGAAACTTGCCATGTTCCTGAGGTTCCTGTGASYBR green[@bib0300]IL4TCACCGGCACTTTCATCCACGGACATAACTTGAGCTGCTGAAGCACAGTTGCAGCTCTGCSYBR green[@bib0160]IL4TCACCGGCACTTTCATCCATTCTCGCTGTGAGGATGTTCASYBR green[@bib0080]***IL6****GCAGAGAACAACCTAAATCTTCCAA****TGATTGAATTGAGACTGGAAGCA****6FAM-CTGGCAGAAGAGGAC-MGBNFQ****TaqMan***This studyIL6CAAATGTGAAGACAGCAAGGAGGCATCTGAAACTCCTGAAGACCGGTAGTGSYBR green, cloning[@bib0300]IL6CAAGTGGCTGAAACACGTAACAAGGCTGAACTGCAGGAAATCCFAM-TCACCTCATCCTACGGAGCCTTG-TAMRATaqMan[@bib0210]***IL8****GGCACCTTGCATCAACATGA****AAGCAGGAAAACTGCCAAGAGA****6FAM-TTCCAAGCTGGCTGTTG-MGBNFQ****TaqMan***This studyIL8CAAGAGCCAGGAAGAAACCAGACCTGATTCTTGGATACCACAGAGAATGCloningThis studyIL8AACCCACTCCACGCCTTTCCATCGGCACACCTCTTTTCCATTGACSYBR green[@bib0160]***IL10****GCTGCGGCGCTGTCA****CTCCACCGCCTTGCTCTTAT****VIC-CGATTTCTGCCCTGTGAG-MGBNFQ****TaqMan***This studyIL10CCTTCGGCAGGGTGAAGACTTTCATGTCAAACTCACTCATGGCTTTGTAGCloningThis studyIL10TCCTTGCTGGAGGACTTTAAGGGTTCCACCGCCTTGCTCTTATTCTCASYBR green[@bib0300]IL10CGAGAACCACGACCCAGAACCGCAGGGTCTTCAGCTTTFAM-TCAAGGAGCACGTGAACTCGCTGG-TAMRATaqMan[@bib0210]***IL12p40****GGTGCTATTCACAAGCTCAAGTATG****GGTTTGATGATGTCCCTGATGA****VIC- TACACCAGCAGCTTC-MGBNFQ****TaqMan, cloning***This studyIL12p40ATCGAGGTTGTGGTGGGTGCTATTTAGGTTCATGGGTGGGTCTGGTTTSYBR green[@bib0300]***IL17****GGACGGTAAACTACCACATGAACTC****AGACTCCCTTCGCAGAACCA****VIC-TCCCCATCCAGCAAGA-MGBNFQ****TaqMan***This studyIL17CGCAATGAGGACCCTGAGAGAggtgacacaggtgcagcccacCloningThis study***Granzyme A****GGATCCTCCCTCTCCCTAAGAA****CCCAGCCTGCAACTTGACA****VIC-ATGATGTCAAACCCGAAAC-MGBNFQ****TaqMan***This studyGranzyme AACTGGGTGTTGACTGCAGCTCACATATCAGAGGGCTTCCAGAATCCloningThis study***MCP1****GCAGCAAGTGTCCCAAAGAAG****GACTGGGGTCAGCGCAGAT****FAM-ATCCTCAAGACATTCCT-MGBNFQ****TaqMan***This studyMCP1GCAGCAAGTGTCCCAAAGAAGgctttgcagtttgggtttggCloning [b](#tblfn0010){ref-type="table-fn"}This studyCCL2 (MCP1)GCTCCCTATTCACTTGCTGTTTCGATTCGATAGCCCTCCAGCTTSYBR green[@bib0270]***TNFα****TGCCATCAGACGGGCTGTA****ACATCCTCGGCCCTTGAAG****VIC-CTTATCTACTCGCAGGTCC-MGBNFQ****TaqMan***This studyTNFαTGGAGCTGACAGACAACCAGCTAATGATGGTGTGGGTAAGGAGCACATSYBR green, cloning[@bib0300]TNFαCCAGATGGCCTCCAACTAATCAGGCTTGTCACTTGGAGTTCGASYBR green[@bib0080] and [@bib0270]TNFαATGTTGTAGCAAACCCTGAAGCTATTGGCCAGGAGGGCATTFAM-ACTCCAATGGCTGAGCCGACGTG-TAMRATaqMan[@bib0210]***IFNα***[a](#tblfn0005){ref-type="table-fn"}***TCCATCCTGAGGAACTACTTCCAG****AGGCACAAGGGCTGTATTGC****6FAM-GAATCTCCCTCTATCTGC-MGBNFQ****TaqMan***This studyIFNα[a](#tblfn0005){ref-type="table-fn"}CTCAGCWGCCACTMCCTCCATGATCTCTGCTCGGACCATCloningThis studyIFNαATGCTCCTGCGACAAATGAGGAGATTCTGCAGCTGCTTGCTGTCAAACSYBR green[@bib0300]***IFNβ****ATATTTCTCCACCACGGTTCTTG****ACTCCACACTGCTGCTGCTTAG****VIC-AACTATAACTTACTTCGATTCCA-MGBNFQ****TaqMan***This studyIFNβATGACCAGCAGGTGTATCCTCCAAAAGCTCCTGAGGATTTCTGCTCloningThis studyIFNβGGTGTATCCTCCAAACTGCTCTCCCACTCCACACTGCTGCTGCTTAGSYBR green[@bib0160]***IFNγ****AACTGGAGAGAGGAGAGTGACAAAA****GTCTTCCTTGATGGTATCCATGC****VIC-TCTCCTTCTACTTGAAACTGT-MGBNFQ****TaqMan***This studyIFNγATGAATTATACAACTATATGCTTAGTTATTTCGATGCTCTGCGGCCTCGCloningThis studyIFNγCCATCAAGGAAGACATGCTTGTCAGGCTGGACCTGCAGATCATTCACAGGAASYBR green[@bib0300]IFNγTGGTGGGCCTCTTTTCTTAGATATAGAAGGAGACAATTTGGCTTTGAFAM-TTGAAGAACTGGAGAGAGGAGAGTGACAAAAAAA-TAMRA**TaqMan**[@bib0210]***Matrix****GACCRATCCTGTCACCTCTGAC****GGGCATTYTGGACAAAKCGTCTACG****6FAM-TGCAGTCCTCGCTCACTGGGCACG-MGBNFQ***TaqManCDC[c](#tblfn0015){ref-type="table-fn"}***Matrix***[d](#tblfn0020){ref-type="table-fn"}[TGTAAAACGACGGCCAGT]{.ul}AGCAAAAGCAGGTAG[CAGGAAACAGCTATGACC]{.ul}AGTAGAAACAAGGTAGTCloningCDC[c](#tblfn0015){ref-type="table-fn"}***ATF4****TTTACCTTCCTGCAACCACTTC****TCATGGTAATGTAAGCAGTAGAGTC****NED-CTGTCCTCCACTCCAGATCATTCCT-MGBNFQ****TaqMan***, cloning[@bib0035]***HPRT****CACTGGGAAAACAATGCAGA****ACAAAGTCAGGTTTATAGCCAACA****NED-TGCTGGTGAAgAGGACCCCTCG-MGBNFQ****TaqMan***, cloning[@bib0240] [e](#tblfn0025){ref-type="table-fn"}***L32****TGGTTA[T]{.ul}AGGAGCAACAAGAAA****GCACATCAGCAGCACTTCA****NED-TGTTGCCCAGTGGCTTCTGG-MGBNFQ****TaqMan***, cloningAdapted from [@bib0240] [e](#tblfn0025){ref-type="table-fn"}***GAPDH****TGCGGCCAAGGCAGTAG****AGGCCATGCCAGTGAGCTT****VIC-CTGAGCTGAATGGGAAG-MGBNFQ****TaqMan***This studyGAPDHAACATCATCCCTGCTTCCACTGGTTGTTGAAGTCGCAGGAGACAACCTSYBR green, cloning[@bib0300]GAPDHTTGCTGACAATCTTGAGGGAGTTCTGCTGATGCCCCCATGTFAM-TCATACTTCTCATGGTTCACACCCATCACG-TAMRATaqMan[@bib0210][^1][^2][^3][^4][^5]

2.2. Oligonucleotide primer and probe generation {#sec0020}
------------------------------------------------

Lyophilized oligonucleotide primers were synthesized by Geneworks (Adelaide, Australia) and dissolved in nuclease-free water (Promega, Madison, USA) at 100 μM. All TaqMan^®^ MGB™ probes were synthesized by Applied Biosystems with a 5′reporter dye (either FAM, NED or VIC) and a 3′non-fluorescent quencher (NFQ).

2.3. Ferrets {#sec0025}
------------

Adult male and female ferrets (weight 500--1500 g) were purchased from independent breeders and housed at CSL Limited (Victoria, Australia) using services provided under a Support Services Agreement. Serum samples were tested by hemagglutination inhibition assay to ensure seronegativity (titer \<10) to currently circulating influenza strains before use. Experiments using ferrets were conducted with approval from the CSL Limited/Zoetis Australia Animal Ethics Committee, in accordance with the Australian Government National Health and Medical Research Council Australian code of practice for the care and use of animals for scientific purposes ([@bib0215]).

2.4. Influenza virus {#sec0030}
--------------------

A/Tasmania/2004/2009 (A(H1N1)pdm09) influenza virus was passaged in the allantoic cavity of embryonated hen\'s eggs and stored in aliquots at −80 °C. To heat inactivate, virus was incubated at 60 °C for 30 min.

2.5. *In vitro* culture of ferret lymph node cells with mitogens or influenza virus {#sec0035}
-----------------------------------------------------------------------------------

Retropharyngeal lymph nodes were collected from naïve ferrets and placed in RPMI-1640 AQ media™ (Sigma--Aldrich, New South Wales, Australia) supplemented with 10% (v/v) fetal calf serum (Interpath Services, Victoria, Australia), 2 mM L-glutamine (SAFC Biosciences, USA), 50 U/ml penicillin/50 μg/ml streptomycin (Sigma--Aldrich) (complete-RPMI). Single cell suspensions were made by mashing the tissue and passing through a sterile 40 μM cell strainer (BD, San Jose, USA). Cell suspensions were washed twice then resuspended in complete-RPMI. Lymph node cells from each ferret (5 × 10^6^ per well) were plated in a 24-well plate in 1 ml complete-RPMI with or without 10 μl of live or heat-inactivated virus (10^4^ TCID~50~) or 5 μg/ml Concanavalin A (ConA), Phytohaemagglutinin (PHA-P), Lipopolysaccharide (LPS), Ionomycin (Iono) or Phorbol 12-myristate 13-acetate (PMA) (all from Sigma--Aldrich) in duplicate or triplicate. Cell cultures were incubated at 37 °C in 5% CO~2~ in a humidified incubator for the indicated periods.

2.6. RNA extraction {#sec0040}
-------------------

Total RNA was extracted from cultured cells using the RNeasy^®^ Mini kit (Qiagen, Victoria, Australia) according to the manufacturer\'s instructions. Briefly, cells from a single well were pelleted and resuspended in 600 μl RLT buffer. The sample was vortexed and then run through a QIAshredder column. RNA was extracted from the supernatant using the Animal Cells Spin protocol, without on-column DNase digestion and eluted with a 30 μl volume. RNA purity was assessed (*A* ~260~/*A* ~280~) using a Nanodrop 1000 spectrophotometer (Thermo Scientific, Massachusetts, USA). RNA was stored at −80 °C.

2.7. Reverse transcription {#sec0045}
--------------------------

For removal of genomic DNA, 800 ng RNA was incubated with 2 units DNase I (RNase-free) (New England Biolabs, Massachusetts, USA) in DNase reaction buffer (final volume 10 μ1) at 37 °C for 10 min. The reaction was terminated by the addition of EDTA (final concentration 5 mM, Sigma--Aldrich) and incubation at 75 °C for 10 min. cDNA was generated using the Superscript III First Strand synthesis System for RT-PCR (Invitrogen, California, USA) with random hexamer primers, according to the manufacturer\'s instructions. RNaseH treatment was performed. A simultaneous reaction without the reverse transcription enzyme was performed in parallel to generate a '-RT' control. The reaction volume resulted in 10 ng initial RNA/μl final cDNA preparation for culture samples, except at points indicated in the text, where 1 ng initial RNA/μl final cDNA preparation was used. cDNA standards were generated in parallel with cDNA test samples for each experiment. cDNA standards were prepared using RNA pooled from a range of test samples within each experiment, with at least 80 μl of 100 ng initial RNA/μl final cDNA standard prepared. Ten-fold and two-fold serial dilutions (five dilutions of each) were prepared and used for standard curve generation for efficiency calculations. cDNA was stored at −20 °C.

2.8. Polymerase chain reaction (PCR) {#sec0050}
------------------------------------

Amplification of gene-specific products was performed using Platinum^®^ Taq DNA Polymerase High Fidelity (Invitrogen) according to the manufacturer\'s instructions. Reactions were run on a S1000™Thermal Cycler (Bio-Rad Laboratories Pty Ltd., New South Wales, Australia).

2.9. Cloning of ferret genes {#sec0055}
----------------------------

Total RNA was extracted from stimulated ferret cell cultures, reverse transcribed and ferret genes amplified by conventional and TaqMan real time PCR, using primers indicated in [Table 1](#tbl0005){ref-type="table"}. Both cDNA and 'no RT' control samples were run to ensure the specificity of the amplification. The matrix influenza gene was amplified from RNA extracted from virus isolate A/California/7/2009 (A(H1N1)pdm09). The products were agarose gel-purified using the QIAquick gel extraction kit (Qiagen) according to the manufacturer\'s instructions. Purified DNA was quantified and ligated into pGEM^®^-T Easy vector (Promega) (IFNγ, IL2, IL4, IL6, IL8, IL10, IL12p40, IL17, MCP1, TNFα, ATF4, HPRT, GAPDH, L32, Matrix) or pCR™4Blunt-TOPO^®^ vector (Invitrogen) (IFNα, IFNβ, IL1α, IL1β, Granzyme A) according to manufacturer\'s instructions. Ligation reactions were transformed into One Shot^®^ TOP10 chemically competent *E. coli* (Invitrogen) by heat shock according to the manufacturer\'s protocol. Positive transformants were identified by PCR using M13 primers (Promega) and gene-specific primers. Plasmid DNA was isolated from bacterial cultures using the QIAprep Spin miniprep kit (Qiagen) according to the manufacturer\'s instructions.

2.10. Real time PCR assay {#sec0060}
-------------------------

The generation of oligonucleotide dimers for each TaqMan primer pair was assessed using Power SYBR^®^ Green PCR MasterMix (Applied Biosystems) with melting curve analysis, according to the manufacturer\'s instructions. Primers which resulted in oligonucleotide dimer generation were redesigned and retested. A comparison between primer pairs was also performed using Power SYBR^®^ Green PCR MasterMix without a melting curve, according to the manufacturer\'s instructions. All other real time PCR assays were performed using the TaqMan^®^ Fast Universal PCR Master Mix (2×), No AmpErase UNG (Applied Biosystems), according to the manufacturer\'s instructions. One microliter cDNA sample was assayed per reaction. Each reaction consisted of 1 cycle of 95 °C for 20 s, followed by 50 cycles of 95 °C for 3 s and 60 °C for 30 s. Real time PCR runs for each gene included cDNA standards (10-fold and 2-fold dilutions, in duplicate), DNA plasmid controls (10-fold dilutions; 5 dilutions), no template control and test samples. When test samples were run over multiple plates for a single gene, DNA plasmid controls were included on each plate and the same mastermix preparation was used for all PCR plates. DNA plasmid controls were reproducible (\<1 Ct difference) between plates. All real time PCR reactions were run on an Applied Biosystems 7500 Fast Real-Time PCR system using the 7500 Fast System Software, Version 1.4.0.25 (Applied Biosystems). Data were analyzed using 7500 Fast System Software, Version 1.4.0.25 except for plasmid DNA efficiency calculations which were determined using 7500 Fast System Software Version 2.0.5.

2.11. Calculations of reaction efficiency, housekeeping gene stability and fold change of gene expression {#sec0065}
---------------------------------------------------------------------------------------------------------

The efficiency of each gene amplification was calculated by plotting the average Ct (*y*-axis) against the logarithm of the input amount of RNA/μl cDNA (*x*-axis). Both a 10-fold dilution series and a 2-fold dilution series were used for each gene and RNA set. Real time PCR efficiency (*E*) = (10^−1/slope^) for 10-fold dilution series ([@bib0245]) and (2^−1/slope^) for 2-fold dilution series. % real time PCR efficiency = (*E*  − 1) × 100. If the standard deviation for the efficiencies determined using 10-fold and 2-fold dilution series fell within 8%, the average efficiency was used in all calculations. If the standard deviation was \>8%, the efficiency calculated using 2-fold dilutions was used. The geometric mean of the efficiencies for the indicated genes was used for the housekeeping gene efficiency. The gene stability of housekeeping genes was calculated using geNorm in qbase+ Version 2.5 (Biogazelle) ([@bib0325]). The fold change of expression of a gene was calculated using relative quantitation with kinetic PCR correction ([@bib0245]). Fold change = (*E* ~target~)^ΔCt target (control−test)^/(*E* ~HKP~)^ΔCt HKP (control−test)^ where 'HKP' was the geometric mean of all housekeeping genes for each data point as indicated in figure legends and 'ΔCt' = Ct control  ^--^  Ct test. "Undetermined' data points in cytokine gene expression were assigned a Ct of "40" to enable calculation of fold change and are indicated in figure legends. The control sample for cultures was unstimulated cells cultured in complete-RPMI.

2.12. Statistics {#sec0070}
----------------

The ability to perform duplex real time PCR was assessed using two tailed *t*-test. Data were analyzed using R software (Version 2.15.3 (2013-03-01)) ([@bib0315]). Expression of target genes in cultured cells was compared using one-way ANOVA and Tukey\'s *post hoc* test (only differences to unstimulated cells are indicated). The mean of duplicate or triplicate wells was calculated and used as a single value for each ferret. \**p*  \< 0.05, \*\**p*  \< 0.01, \*\*\**p*  \< 0.001.

3. Results {#sec0075}
==========

3.1. Development of a two-step TaqMan real time PCR assay to measure expression of ferret immune mediator and housekeeping genes {#sec0080}
--------------------------------------------------------------------------------------------------------------------------------

Cytokine, chemokine and housekeeping genes were amplified from total mRNA generated from cultures of ferret lymph node cells using primers targeting conserved regions of each gene. All genes cloned in this study were sequenced and the sequences run in BLASTn whereby they matched other published and predicted sequences for the corresponding ferret gene on GenBank, especially those derived from the ferret genome project ([@bib0070]) ([Table 2](#tbl0010){ref-type="table"} ). Sequences generated in this study were also translated and all sequences aligned to known sequences of the corresponding proteins from other species in GenBank (data not shown). All primer/probe sets for the TaqMan real time PCR assay ([Table 1](#tbl0005){ref-type="table"}) were tested to ensure specificity and optimum efficiency using plasmid DNA standards. The absence of non-specific amplicons was verified for all primer/probe sets ([Fig. 1](#fig0005){ref-type="fig"}A). The % efficiency of each primer/probe set was consistent and between 94 and 103% which is equivalent to an efficiency of 1.94--2.03 ([Fig. 1](#fig0005){ref-type="fig"}B), indicating that the template doubled after each cycle during exponential amplification. The correlation co-efficient for all samples was between 0.980 and 0.999 (data not shown). The sensitivity of the primer/probe sets for each gene was consistent across the different TaqMan assays, with all genes detected down to 0.0001 pg DNA plasmid (average 25.2 RNA copies), except GAPDH, which was detected down to 0.00001 pg DNA (2.5 RNA copies) ([Table 3](#tbl0015){ref-type="table"} ). The limits of detection were consistent for previously published TaqMan primer/probes sets ([@bib0210]) and all tested SYBR Green primer sets ([@bib0300], [@bib0080], [@bib0270], [@bib0160]) when analyses were performed using the same samples ([Table 3](#tbl0015){ref-type="table"}). There was no change in the sensitivity of the assay when primer/probes were mixed in the indicated duplex real time PCR reactions ([Fig. 1](#fig0005){ref-type="fig"}C), or when plasmid samples were prepared in pools ([Fig. 1](#fig0005){ref-type="fig"}D), or a combination of both duplex real time PCR reactions and sample pools ([Fig. 1](#fig0005){ref-type="fig"}E), except for L32, which was less sensitive when assayed with other genes ([Fig. 1](#fig0005){ref-type="fig"}E).Table 2Ferret genes amplified in this study and sequence similarly to other published ferret experimental and predicted sequences by BLASTn. Features of the BLASTn alignments are indicated. Note that the aligned sequences are divided into sequences submitted from laboratory-derived experimental data as well as sequences from the ferret genome which have been predicted and designated using the gene prediction tool.GeneGenBank accession \# generated for this studySize of gene generated for this study (bp)BLASTn resultsNo. of alignments[a](#tblfn0030){ref-type="table-fn"}Query coverage (%)[b](#tblfn0035){ref-type="table-fn"}Identity (%)[c](#tblfn0040){ref-type="table-fn"}GenBank accession numbersExperimental mRNA sequencesPredicted mRNA sequences[d](#tblfn0045){ref-type="table-fn"}IL1αKJ83121395319598--[XM_004771000.1](ncbi-n:XM_004771000.1){#intr0010}IL1βKJ83121273738599--100[AB301555.1](ncbi-n:AB301555.1){#intr0015}, [EU835490.1](ncbi-n:EU835490.1){#intr0020}[XM_004826192.1](ncbi-n:XM_004826192.1){#intr0025}IL2KJ83121123229899KC585003.1[XM_004747973.1](ncbi-n:XM_004747973.1){#intr0030}IL4KJ831210413495--10099--100EF49062.1, [EF368210.1](ncbi-n:EF368210.1){#intr0035}, KC585004.1[XM_004745005.1](ncbi-n:XM_004745005.1){#intr0040}IL6KJ831209143510097--100[EF492063.1](ncbi-n:EF492063.1){#intr0045}, [EF368209.1](ncbi-n:EF368209.1){#intr0050}, [EU753358.1](ncbi-n:EU753358.1){#intr0055}[XM_004743357.1](ncbi-n:XM_004743357.1){#intr0060}, [XM_004743356.1](ncbi-n:XM_004743356.1){#intr0065}IL8KJ831208384477--10099--100[EU835489.1](ncbi-n:EU835489.1){#intr0070}, [EU477256.1](ncbi-n:EU477256.1){#intr0075}[AB300565.1](ncbi-n:AB300565.1){#intr0080}, [XM_004766277.1](ncbi-n:XM_004766277.1){#intr0085}IL10KJ8312073492100100[EF368212.1](ncbi-n:EF368212.1){#intr0090}[XM_004756192.1](ncbi-n:XM_004756192.1){#intr0095}IL12p40KJ83120670297100[EF368213.1](ncbi-n:EF368213.1){#intr0100}[XM_004737709.1](ncbi-n:XM_004737709.1){#intr0105}IL17KJ83120521619999--[XM_004771883.1](ncbi-n:XM_004771883.1){#intr0110}Granzyme AKJ83120346419899--[XM_004744658.1](ncbi-n:XM_004744658.1){#intr0115}MCP1KJ831216135110099--[XM_004747089.1](ncbi-n:XM_004747089.1){#intr0120}TNFαKJ8312171196100100KC713805.1, [EF492065.1](ncbi-n:EF492065.1){#intr0125}, [EF368211.1](ncbi-n:EF368211.1){#intr0130}[XM_004826757.1](ncbi-n:XM_004826757.1){#intr0135}, [XM_004781005.1](ncbi-n:XM_004781005.1){#intr0140}, [XM_004781004.1](ncbi-n:XM_004781004.1){#intr0145}IFNαKJ8312014714310088--99[EU863622.1](ncbi-n:EU863622.1){#intr0150}, [EU863621.1](ncbi-n:EU863621.1){#intr0155}, [EU863616.1](ncbi-n:EU863616.1){#intr0160}, [EU863624.1](ncbi-n:EU863624.1){#intr0165}, [EU863619.1](ncbi-n:EU863619.1){#intr0170}, [EU863620.1](ncbi-n:EU863620.1){#intr0175}, [EU863617.1](ncbi-n:EU863617.1){#intr0180}, [EU091340.1](ncbi-n:EU091340.1){#intr0185}, [EU863615.1](ncbi-n:EU863615.1){#intr0190}, [EU863614.1](ncbi-n:EU863614.1){#intr0195}, [EU863613.1](ncbi-n:EU863613.1){#intr0200}, [EU543213.1](ncbi-n:EU543213.1){#intr0205}, [EU395773.1](ncbi-n:EU395773.1){#intr0210}, [EU863618.1](ncbi-n:EU863618.1){#intr0215}, [EU863623.1](ncbi-n:EU863623.1){#intr0220}, [EF368207.1](ncbi-n:EF368207.1){#intr0225}[XM_004761809.1](ncbi-n:XM_004761809.1){#intr0230}, [XM_004803999.1](ncbi-n:XM_004803999.1){#intr0235}, [XM_004761818.1](ncbi-n:XM_004761818.1){#intr0240}, [XM_004803994.1](ncbi-n:XM_004803994.1){#intr0245}, [XM_004804009.1](ncbi-n:XM_004804009.1){#intr0250}, [XM_004761812.1](ncbi-n:XM_004761812.1){#intr0255}, [XR_200135.1](ncbi-n:XR_200135.1){#intr0260}, [XM_004804015.1](ncbi-n:XM_004804015.1){#intr0265}, [XM_004761833.1](ncbi-n:XM_004761833.1){#intr0270}, [XM_004804014.1](ncbi-n:XM_004804014.1){#intr0275}, [XM_004804000.1](ncbi-n:XM_004804000.1){#intr0280}, [XM_004761810.1](ncbi-n:XM_004761810.1){#intr0285}, [XM_004761838.1](ncbi-n:XM_004761838.1){#intr0290}, [XM_004761834.1](ncbi-n:XM_004761834.1){#intr0295}, [XM_004804013.1](ncbi-n:XM_004804013.1){#intr0300}, [XR_200137.1](ncbi-n:XR_200137.1){#intr0305}, [XM_004761835.1](ncbi-n:XM_004761835.1){#intr0310}, [XR_203184.1](ncbi-n:XR_203184.1){#intr0315}, [XM_004804001.1](ncbi-n:XM_004804001.1){#intr0320}, [XM_004761836.1](ncbi-n:XM_004761836.1){#intr0325}, [XM_004761811.1](ncbi-n:XM_004761811.1){#intr0330}, [XM_004803995.1](ncbi-n:XM_004803995.1){#intr0335}, [XM_004804010.1](ncbi-n:XM_004804010.1){#intr0340}, [XM_004761817.1](ncbi-n:XM_004761817.1){#intr0345}, [XM_004761815.1](ncbi-n:XM_004761815.1){#intr0350}, [XM_004761814.1](ncbi-n:XM_004761814.1){#intr0355}, [XM_004761840.1](ncbi-n:XM_004761840.1){#intr0360}IFNβKJ83121552439998--100[EF368208.1](ncbi-n:EF368208.1){#intr0365}, [EF581890.1](ncbi-n:EF581890.1){#intr0370}[XM_004761820.1](ncbi-n:XM_004761820.1){#intr0375}IFNγKJ831214451497--10099[EF492064.1](ncbi-n:EF492064.1){#intr0380}, [AB300566.1](ncbi-n:AB300566.1){#intr0385}, [EF368214.1](ncbi-n:EF368214.1){#intr0390}[XM_004752468.1](ncbi-n:XM_004752468.1){#intr0395}ATF4KJ831200143410099--100--[XM_004743292.1](ncbi-n:XM_004743292.1){#intr0400}, [XM_004825436.1](ncbi-n:XM_004825436.1){#intr0405}, [XM_004786859.1](ncbi-n:XM_004786859.1){#intr0410}, [XM_004779758.1](ncbi-n:XM_004779758.1){#intr0415}HPRTKJ83120212529898--[XM_004815015.1](ncbi-n:XM_004815015.1){#intr0420}, [XM_004778420.1](ncbi-n:XM_004778420.1){#intr0425}GAPDHKJ831204250410098--99[EF392835.1](ncbi-n:EF392835.1){#intr0430}[XM_004766704.1](ncbi-n:XM_004766704.1){#intr0435}, [XM_004766703.1](ncbi-n:XM_004766703.1){#intr0440}, [XM_004766702.1](ncbi-n:XM_004766702.1){#intr0445}L32KJ83121810419697--[XM_004738566.1](ncbi-n:XM_004738566.1){#intr0450}[^6][^7][^8][^9]Fig. 1Development of TaqMan assay to detect expression of ferret immune mediators and housekeeping genes using plasmid DNA standards. (A) The specificity of all primer/probe sets was tested against all DNA plasmid standards (1 pg) by TaqMan real time PCR and assessed by gel electrophoresis. An example is shown. (B) The efficiency of each reaction was determined using a 10-fold dilution standard curve. Cytokine and chemokine (black circles) and housekeeping (white circles) genes are shown. The mean efficiency for all genes is indicated by the horizontal line. The reaction efficiency (*E*) is indicated with the corresponding % efficiency, with the ideal value '*E* = 2' and the acceptable range (1.9--2.1), indicated. (C) One or two primer/probe sets were combined in a real time PCR reaction and assayed against each of the single target genes. (D) One primer/probe set was assayed against the target gene in a pool (four to seven plasmids) or alone. (E) One or two primer/probe sets were combined in a real time PCR reaction and assayed against the target gene in a paired pool. (C--E) All samples were run in triplicate, with mean and standard deviation indicated. \**p* \< 0.05.Table 3Comparison of the sensitivity of TaqMan and SYBR Green real time PCR assays. All reactions were performed with the same plasmid standard, except in cases where the appropriate plasmid standard encompassing both primer sets was not available, and a cDNA sample was used instead. The same samples were used to compare the TaqMan assays in this study with either previously published TaqMan assays or previously published SYBR Green assays for an individual gene. Individual lines indicate different experiments.Gene targetSensitivity of real time reaction[a](#tblfn0050){ref-type="table-fn"}References for other published studiesTaqMan primer/probes from this studyTaqMan primer/probes from other published studiesSYBR Green primers from other published studiesTaqMan assayTaqMan AssaySYBR Green assayCopy number/RNA amountAverage Ct ± std devCopy number/RNA amountAverage Ct ± std devCopy number/RNA amountAverage Ct ± std devIL1α20.8[b](#tblfn0055){ref-type="table-fn"}34.8 ± 0.1n.a.n.a.IL1β21.9[b](#tblfn0055){ref-type="table-fn"}33.8 ± 0.321.9[b](#tblfn0055){ref-type="table-fn"}35.3 ± 0.2[@bib0080] and [@bib0270]IL226.3[b](#tblfn0055){ref-type="table-fn"}34.6 ± 0.326.3[b](#tblfn0055){ref-type="table-fn"}29.9 ± 0.8[@bib0300]IL426.6[b](#tblfn0055){ref-type="table-fn"}34.7 ± 0.526.6[b](#tblfn0055){ref-type="table-fn"}35.3 ± 0.4[@bib0160]IL426.6[b](#tblfn0055){ref-type="table-fn"}34.7 ± 0.526.6[b](#tblfn0055){ref-type="table-fn"}33.2 ± 0.1.[@bib0300]IL628.9[b](#tblfn0055){ref-type="table-fn"}36.8 ± 0.328.9[b](#tblfn0055){ref-type="table-fn"}33.6 ± 0.9[@bib0300]IL60.1 ng38.2 ± 0.60.1 ng38.7 ± 0.7[@bib0210]IL826.9[b](#tblfn0055){ref-type="table-fn"}37.1 ± 0.626.9[b](#tblfn0055){ref-type="table-fn"}34.0 ± 0.4[@bib0160]IL1027.1[b](#tblfn0055){ref-type="table-fn"}35.0 ± 0.327.1[b](#tblfn0055){ref-type="table-fn"}33.9 ± 0.9[@bib0300]IL1027.1[b](#tblfn0055){ref-type="table-fn"}33.3 ± 0.527.1[b](#tblfn0055){ref-type="table-fn"}34.6 ± 0.5[@bib0210]IL12p4029.6[b](#tblfn0055){ref-type="table-fn"}33.2 ± 0.4n.a.[d](#tblfn0065){ref-type="table-fn"}n.a.[d](#tblfn0065){ref-type="table-fn"}IL12p40[d](#tblfn0065){ref-type="table-fn"}1 ng33.9 ± 0.41 ng34.6 ± 1.2[@bib0300]IL1728.2[b](#tblfn0055){ref-type="table-fn"}33.9 ± 0.4n.a.n.a.Granzyme A22.8[b](#tblfn0055){ref-type="table-fn"}35.3 ± 0.7n.a.n.a.MCP129.0[b](#tblfn0055){ref-type="table-fn"}34.9 ± 0.2n.a.[d](#tblfn0065){ref-type="table-fn"}n.a.[d](#tblfn0065){ref-type="table-fn"}MCP1[d](#tblfn0065){ref-type="table-fn"}0.1 ng33.3 ± 0.31 ng34 ± 0.9[@bib0270]TNFα29.1[b](#tblfn0055){ref-type="table-fn"}34.1 ± 0.629.1[b](#tblfn0055){ref-type="table-fn"}31.1 ± 0.6[@bib0300]TNFα[d](#tblfn0065){ref-type="table-fn"}0.1 ng33.7 ± 0.60.1 ng34.5 ± 0.7[@bib0080] and [@bib0270]TNFα [d](#tblfn0065){ref-type="table-fn"}0.1 ng34.6 ± 0.50.1 ng35.0 ± 0.6[@bib0210]IFNα22.9[b](#tblfn0055){ref-type="table-fn"}34.7 ± 0.822.9[b](#tblfn0055){ref-type="table-fn"}34.5 ± 0.8[@bib0300]IFNβ22.5[b](#tblfn0055){ref-type="table-fn"}35.7 ± 0.722.5[b](#tblfn0055){ref-type="table-fn"}31.6 ± 0.4[@bib0160]IFNγ26.3[b](#tblfn0055){ref-type="table-fn"}35.1 ± 0.526.3[b](#tblfn0055){ref-type="table-fn"}33.6 ± 1.1[@bib0300]IFNγ26.3[b](#tblfn0055){ref-type="table-fn"}34.8 ± 0.226.3[b](#tblfn0055){ref-type="table-fn"}35.9 ± 0.1[@bib0210]Matrix23.3[b](#tblfn0055){ref-type="table-fn"}37.2 ± 0.8n.a.n.a.ATF428.9[b](#tblfn0055){ref-type="table-fn"}33.9 ± 0.5n.a.n.a.HPRT29.1[b](#tblfn0055){ref-type="table-fn"}35.9 ± 0.3n.a.n.a.GAPDH\<10[c](#tblfn0060){ref-type="table-fn"}37.6 ± 0.92.8[c](#tblfn0060){ref-type="table-fn"}37.8 ± 1[@bib0300]GAPDH[d](#tblfn0065){ref-type="table-fn"}0.3 ng33.4 ± 1.50.03 ng31.7 ± 0.6[@bib0210]L3229.3[b](#tblfn0055){ref-type="table-fn"}36.6 ± 0.7n.a.n.a.[^10][^11][^12][^13][^14]

3.2. Optimization of two-step real time PCR assay using RNA from cultured lymphoid cells {#sec0085}
----------------------------------------------------------------------------------------

To enable comparison between samples from multiple ferrets, the expression of all genes was determined as a fold change, using the calculation for relative quantification to housekeeping gene(s), with kinetic PCR efficiency adjustment ([@bib0245]). As this equation relies on consistency between samples in the RNA quantity assayed, and the optimum reaction efficiency, as well as minimal fluctuation in the expression of housekeeping genes (endogenous controls) ([@bib0240], [@bib0165], [@bib0035]), these parameters were optimized using RNA extracted from cultured ferret lymph node cells stimulated with mitogens or with influenza virus.

As the RNA quantity varied between samples (range 1.39--11.17 μg/well, [Fig. 2](#fig0010){ref-type="fig"}A), we first determined the minimum amount of RNA for use in the TaqMan real time RT-PCR assay. The reproducibility of both reverse transcription ([Fig. 2](#fig0010){ref-type="fig"}B) and real time PCR ([Fig. 2](#fig0010){ref-type="fig"}C) steps was assessed separately for samples with different amounts of RNA. A minimum of 1 ng total RNA produced highly reproducible results for both reverse transcription and real time PCR steps (standard deviation \<0.4Ct) and the Ct value was able to detect gene expression ([Fig. 2](#fig0010){ref-type="fig"}B and C) where Ct (cycle threshold) is the cycle number at which the fluorescent signal of the reaction crosses the threshold to exceed background level. A set of cDNA standards was generated from the mitogen- and influenza virus-stimulated ferret lymph node cells and the reaction efficiency for all genes determined (examples of graphs and calculations for efficiency are shown in [Fig. 3](#fig0015){ref-type="fig"}A, compilation of efficiencies for all genes is shown in [Fig. 3](#fig0015){ref-type="fig"}B and C). Although the reaction efficiencies clustered for each of the ferret lymph node cDNA preparations (mitogen or virus stimulation in [Fig. 3](#fig0015){ref-type="fig"}B and C, respectively), the efficiencies using the 10-fold dilutions of cDNA samples were more broadly spread than for the plasmid preparations (compare 10-fold dilution in [Fig. 3](#fig0015){ref-type="fig"}B and C with [Fig. 1](#fig0005){ref-type="fig"}B). Furthermore, analysis of the 10-fold dilutions indicated some variability due to low level cytokine mRNA expression (such as for IL1α, IFNα). Use of 2-fold dilutions of the cDNA standards enabled the efficiency to be determined and data points overlaid with the data points generated by the 10-fold dilution series, suggesting this approach is acceptable to determine cytokine levels ([Fig. 3](#fig0015){ref-type="fig"}A). To minimize the potential effect of initial sampling variability, a calculation of gene stability was performed for housekeeping genes ([@bib0325]). Assessment of the stability of expression of housekeeping genes following stimulation with different mitogens ([Fig. 4](#fig0020){ref-type="fig"}A) or influenza virus ([Fig. 4](#fig0020){ref-type="fig"}B) demonstrated that expression of some housekeeping genes, such as GAPDH, was affected more than others and this effect was specific to different stimuli (compare [Fig. 4](#fig0020){ref-type="fig"}A to B). As GAPDH was more variable in expression than the other housekeeping genes; ATF4, L32 and HPRT following mitogen stimulation, GAPDH was excluded and a combination housekeeping genes was used as a reference ([Fig. 4](#fig0020){ref-type="fig"}C). In contrast, following virus stimulation, all housekeeping genes were relatively stable and thus all housekeeping genes were able to be used as references ([Fig. 4](#fig0020){ref-type="fig"}D). These data suggests that reaction efficiencies and the most stable housekeeping genes should be determined for a type of sample set of cDNA under analysis to be able to accurately calculate gene expression.Fig. 2Quantification of total RNA isolated from cultured ferret lymphoid cells and assessment of variability in reverse transcription and real time PCR assay steps. (A) Cells from naïve ferret lymph nodes were cultured with or without the indicated mitogens or with influenza virus for 24 or 48 h, respectively. Each point indicates the average amount of RNA isolated from duplicate or triplicate culture wells of cells from a single ferret. Total RNA was extracted and quantified by spectrophotometry. The mean for each group is indicated by horizontal bar. (B) cDNA was reverse transcribed from the same RNA samples on three separate occasions. All samples were assessed in the same real time PCR assay detecting the housekeeping gene ATF4. (C) cDNA was reverse transcribed in bulk and assayed detecting ATF4, in four separate real time PCR reactions. (B, C) Individual data points represent each experiment. The line of best fit was calculated using linear regression.Fig. 3Assessment of efficiency of TaqMan assay for ferret cytokine mRNAs using cDNA. The efficiency of each reaction was determined using standard curves generated from cDNA pools in 10-fold or 2-fold dilution series (average of duplicate values are shown). (A) Examples of calculations for efficiency using cDNA standards from mitogen-stimulated cells to detect IL1α and IL8 expression. (B, C) The reaction efficiencies for each gene for a set of cDNA standards (10-fold and 2-fold dilutions) were calculated. The cDNA standards were generated using mitogen (B)- or influenza virus (C)-stimulated cells. Housekeeping genes (ATF4, HPRT, GAPDH, L32) are indicated by white circles, outliers are indicated by white squares, all other genes are indicated by black circles. Mean is indicated for each group by horizontal line. The % efficiency and corresponding efficiency (*E*) are indicated.Fig. 4Assessment of housekeeping gene expression in cultured ferret lymphoid cells. Expression of housekeeping genes was determined in lymph node cells from naïve ferrets stimulated with mitogens for 24 h (A) or with influenza virus for 48 h (B). All stimulations were performed in duplicate or triplicate wells for each ferret and each data point represents the mean Ct of the culture wells for a single ferret. (A, B) Mean for each group is indicated by horizontal line and p value indicates overall differences between groups. (C, D) The 'average pairwise variation of a gene with all other housekeeping genes' (M) after stepwise exclusion of the more variable genes as calculated using geNorm ([@bib0325]). The least stable gene is shown on the left, the most stable gene on the right.

3.3. Stimulation of ferret lymph node cells with mitogens or influenza virus differentially modulates expression of innate and adaptive immune mediators {#sec0090}
--------------------------------------------------------------------------------------------------------------------------------------------------------

To test the ability of ferret leukocytes to produce mRNA cytokines and chemokines, lymph node cells from naïve ferrets were cultured with various mitogens known to activate T and B lymphocyte and macrophage/monocyte responses ([Fig. 5](#fig0025){ref-type="fig"} ) and with live or heat inactivated influenza virus ([Fig. 6](#fig0030){ref-type="fig"} ) and the cytokine and chemokine expression profiles were determined (summarized in [Table 4](#tbl0020){ref-type="table"} ). Culture with the lectins Concanavalin A (ConA) or Phytohaemagglutinin (PHA), which act by cross linking T cell receptors *via* sugars on the surface of human T lymphocytes ([@bib0050]), induced similar cytokine profiles, increasing expression of IL2, IL4, IL6, IL10, IL17, Granzyme A, TNFα and IFNγ, most with high fold changes, consistent with effective stimulation of T lymphocytes ([Fig. 5](#fig0025){ref-type="fig"}). PHA also induced expression of IL12p40 mRNA. The addition of Con A or PHA significantly reduced the expression of MCP-1 and IFNα in their respective cultures ([Fig. 5](#fig0025){ref-type="fig"}). Ionomycin and Phorbol 12-myristate 13-acetate (PMA) are mitogenic for lymphocytes as they bypass surface receptors and activate cellular responses by increasing intracellular calcium and directly activating protein kinase C, respectively ([@bib0220], [@bib0005]). Culture with ionomycin significantly increased mRNA expression of IL2, IL10 and IFNγ. PMA significantly increased levels of TNFα and IL1β. Expression of IFNα and IL12p40 mRNAs was significantly reduced upon culture with Ionomycin or PMA ([Fig. 5](#fig0025){ref-type="fig"}).Fig. 5Gene expression in mitogen-stimulated ferret lymph node cells. Lymph node cells from four naïve ferrets were stimulated with the indicated mitogens for 24 h, then RNA was isolated, reverse transcribed and assayed by real time PCR using 10 ng initial RNA/reaction. Each data point represents the average fold change of duplicate or triplicate culture wells compared to the geometric mean of L32, HPRT and ATF4 housekeeping genes. IFNβ was not detected. Horizontal bars indicate the mean for each group; dotted line indicates no fold change. Statistical difference in fold-change compared to cells with no stimulation is indicated.Fig. 6Gene expression in influenza virus-stimulated ferret lymph node cells. Lymph node cells from four naive ferrets were stimulated with the live or heat inactivated (HI) A (H1N1)pdm09 virus for 48 h, then RNA was isolated, reverse transcribed and assayed by real time PCR using 10 ng initial RNA/reaction. Each data point represents the average fold change of duplicate or triplicate culture wells compared to the geometric mean of GAPDH, L32, HPRT and ATF4 housekeeping genes. The influenza A matrix gene was not detected in the 'none' sample and was substituted with a value of 40; all other genes had a detectable Ct in all samples. Horizontal bars indicate the mean for each group; dotted line indicates no fold change. Statistical difference in fold-change compared to cells with no stimulation is indicated.Table 4Changes in cytokine and chemokine expression following stimulation of ferret lymph node cells with mitogens or influenza virus.GeneStimulusConAPHAIonoPMALPSInfluenza virusIL1αnc[a](#tblfn0070){ref-type="table-fn"}ncnc+[b](#tblfn0075){ref-type="table-fn"}+↓\*\*\*IL1βncncnc+\*[d](#tblfn0085){ref-type="table-fn"}+↓\*\*\*IL2+\*\*\*+\*\*\*+\*\*\*+ncncIL4+\*+\*\*++ncncIL6+\*+nc↓[c](#tblfn0080){ref-type="table-fn"}+\*ncIL8ncncnc++↓\*\*\*IL10+\*\*\*++\*\*nc+ncIL12p40nc+\*\*↓\*↓\*\*\*ncncIL17+++ncncncGranzyme A+\*\*+++nc+\*\*MCP1↓\*\*↓\*↓ncnc↓\*\*TNFα+\*\*\*+↓+\*\*ncncIFNα↓\*\*↓\*\*↓\*\*↓\*\*↓+\*\*IFNβn.d.[e](#tblfn0090){ref-type="table-fn"}n.d.n.d.n.d.n.d.ncIFNγ+\*\*\*+\*+\*\*\*ncnc+\*\*\*[^15][^16][^17][^18][^19]

Lipopolysaccharide (LPS) is a potent activator of naïve and mature B lymphocytes ([@bib0015], [@bib0285]), monocytes and macrophages. Stimulation with LPS induced significant levels of IL6 and a small increase in expression of IL8. No expression of IFNβ was detected in any culture stimulated with mitogen. Real time PCR assays performed as duplex PCRs with the same primer pairs as shown in [Fig. 1](#fig0005){ref-type="fig"}E detected up- and down-regulation of the same cytokines as assays using single primer/probe sets (data not shown). Real time assays run with 10-fold less cDNA (1 ng RNA/μl cDNA) for IL6, IFNγ, L32 and ATF4 detected the same fold differences (data not shown).

Culture of ferret leukocytes with live or heat inactivated A(H1N1)pdm09 virus for 48 h induced different cytokine profiles from those stimulated by mitogens ([Fig. 6](#fig0030){ref-type="fig"}). Live A(H1N1)pdm09 virus induced a significant reduction in expression of IL1α, IL1β, IL8 and MCP1, as well as large increases in expression of Granzyme A, IFNα and IFNγ, whereas heat inactivated virus induced negligible effect on cytokine expression. Note that cultures assayed at 24 and 72 h also showed similar results (data not shown).

4. Discussion {#sec0095}
=============

In this study, we describe a series of real time TaqMan RT-PCR assays that can be used to characterize the expression of cytokines and chemokines of the innate and adaptive immune response in ferrets. The sequences of the ferret genes cloned in this study and used for design of the primers and probes, aligned with other previously published sequences as well as with the predicted sequences from the Ferret Genome Project ([@bib0070]). Previous studies have predominantly utilized SYBR green real time RT-PCR and required a minimum quantity of 10 ng initial RNA per reaction for detection of a single ferret cytokine or chemokine ([@bib0305], [@bib0195], [@bib0190]). Here we have demonstrated that 1 ng total RNA is sufficient in a TaqMan real time RT-PCR assay to detect most cytokine and chemokine mRNAs. By multiplexing reactions with probes using different fluorochromes, samples with low amounts of RNA, such as ferret respiratory samples ([@bib0290]), may still be analyzed using this assay without loss of sensitivity, providing a significant sample and cost reduction. In our study we showed that a minimum of duplex assays could be used, mixing primers and probes specific for a housekeeping gene and a cytokine/chemokine gene or two cytokine/chemokines genes. With further optimization, a higher number of targets may be able to be multiplexed.

Real time PCR results can be reported in copy number or as fold change both compared to a control, depending on whether absolute or relative quantification is required ([@bib0100], [@bib0245]). Absolute quantification requires DNA or *in vitro* transcribed RNA standards to be included in each reaction, whereas relative quantification can be achieved by including a set of cDNA standards generated from the sample of interest, or no standards at all, if the efficiency of each reaction is identical ([@bib0245]). As it is difficult to maintain the stability of a large number of RNA standards ([@bib0100]), absolute quantification was not used in this study. Furthermore, the necessity for a standard curve on each assay plate would increase the number of plates required for an experiment, which may become impractical when assaying a large number of test samples. Calculation of fold change relative to housekeeping gene(s), with kinetic PCR efficiency adjustment, incorporates corrections for reverse transcription efficiency and PCR efficiency, as well as individual sample addition, by using normalizer housekeeping genes. In our study, although initial assays using DNA plasmids demonstrated that the efficiencies of all primer/probe sets in the TaqMan real time PCR assays were consistent, data from cultures of ferret lymph nodes and our preliminary data with ferret respiratory samples (not shown) indicate that the efficiency of reactions clusters for each set of cDNAs and appropriate housekeeping genes need to be determined for each sample type. The importance of careful assessment of suitable housekeeping genes for real time PCR has also been demonstrated for human, canine and ferret tissues ([@bib0240], [@bib0165], [@bib0035]). As real time PCR measures the Ct in the exponential phase of the PCR, it has been argued that the effect of differences in PCR efficiency is minor ([@bib0100]). However, we anticipate this TaqMan assay will be useful for various ferret samples, particularly nasal washes or bronchoalveolar lavages, and respiratory tissues in virus-infected ferrets, which may have low amounts of RNA, and variable levels of expression of cytokine and chemokine genes. Given the variability in the cellular composition of samples from different sites (*e.g.* lung tissue compared to lymph node), incorporation of corrections for reverse transcription and PCR efficiency and housekeeping gene variability are necessary in these samples.

The cytokine profiles induced by stimulation of lymph node cells from naïve ferrets with mitogens were consistent with those reported in studies using human and other animal leukocytes. Stimulation of ferret lymph node cells with ConA induced similar profiles to cultures of mouse splenocytes ([@bib0045]), human PBMCs ([@bib0005], [@bib0335], [@bib0260]), woodchuck PMBCs ([@bib0180]) and calf CD4^+^ and CD8^+^ PBMCs ([@bib0310]) stimulated with ConA. Of interest, ConA has been shown to induce expression of IL1β and low levels of IL1α in human PBMCs ([@bib0335]), but we did not detect increases in either cytokine in ferret lymph node cells. We also used the other published primers for detecting IL1β ([@bib0080], [@bib0270]) with our samples but could not detect expression (data not shown). Increased levels of TNFα, IL2 and IFNγ were reported following culture of human PBMCs with PHA ([@bib0105], [@bib0010]), and we obtained similar results using ferrets cells. Ionomycin and PMA have been shown to increase production of IL2, IL4 and IFNγ in human PBMCs ([@bib0130]) and IL4, IL8, IFNγ and TNFα in ferret BAL, splenocytes or PBLs ([@bib0275], [@bib0170]); all of these genes were also upregulated in this current study following stimulation of ferret leukocytes with either Ionomycin or PMA. LPS is a potent stimulator of IL1α and β, IL6, and TNFα from human PBMCs ([@bib0005], [@bib0335], [@bib0175], [@bib0055]) and IL6 and TNFα from mouse PBMCs and macrophages ([@bib0140]). Similarly, IL1α and β, IL6, and IL8, but not TNFα, were increased in LPS-stimulated ferret lymph node cultures. A similar study in which ferret PBMCs were cultured with LPS detected expression of IL6, IFNγ, IL10 and TNFα by TaqMan real time RT-PCR at earlier timepoints, suggesting the kinetics of the response are important ([@bib0210]). We also assessed TNFα expression using previously published TaqMan primers and probe ([@bib0210]) and SYBR Green primers ([@bib0080], [@bib0270]) with our samples and the profiles were consistent with those obtained with the TaqMan assay designed in this study (data not shown).

Stimulation of ferret lymph node cultures with live influenza virus resulted in upregulated expression of IFNγ and Granzyme A, and these markers of T lymphocyte (and NK cell) activation, are also upregulated following stimulation of human PBMCs with influenza virus ([@bib0085], [@bib0320]). IL2 was not detected in ferret cells, although it has been detected by flow cytometry in human cells following *in vitro* influenza virus stimulation ([@bib0280], [@bib0110]). Increased expression of type I interferons (also seen upon virus stimulation in human PBMCs ([@bib0085])) and a corresponding decrease in MCP1 expression was induced in ferret cells following exposure to influenza virus. This inverse relationship has also been reported in mice co-infected with bacteria and influenza virus and is suggested to be due to type I interferon-mediated suppression of macrophages ([@bib0200]). This may also explain the reductions in IL1 and IL8 in ferret lymph node cells cultured with virus as both these mediators would be typically produced by macrophages in the lymph node. The significant down-regulation of IFNα and variable expression of MCP-1 and IL12p40 in cultures stimulated with mitogens may also be due to altered activation of cells of the innate immune system. The magnitude and differential patterns of gene expression detected here indicate that these assays can be used for more detailed investigations of the cell types and pathways ([@bib0095]) that contribute to immune responses in the ferret.

In summary, we have described a series of TaqMan real time RT-PCR assays to quantify a large number of cytokines and chemokines in the ferret model. Our study highlights key technical aspects of these assays to maximize the analysis of immune mediators induced from ferret cells. The particular cytokine and chemokine profiles induced in ferret cells following stimulation with mitogens or influenza virus were consistent with those reported for other species. Overall these data demonstrate the usefulness of these assays to enhance our understanding of influenza virus infection and other diseases that use the ferret model.
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[^1]: Targeted to all IFNα subtypes ([@bib0075], [@bib0120]).

[^2]: Note same forward primer as TaqMan assay.

[^3]: Primers obtained from the Centers for Disease Control, Atlanta, USA through WHO (<http://www.who.int/csr/resources/publications/swineflu/sequencing_primers/en/index.html>).

[^4]: M13 Tag underlined.

[^5]: Nucleotide changes to sequences underlined.

[^6]: BLASTn sequences that aligned with the ferret sequence generated in this study.

[^7]: Relationship between the length the of the BLASTn sequence and the ferret sequence generated in this study. \<100% indicates that the BLASTn sequence is shorter. Range for all BLASTn sequences is indicated.

[^8]: Range for all BLASTn sequences is indicated.

[^9]: Predicted using the NCBI eukaryotic gene prediction tool, Gnomon.

[^10]: n.a.: not applicable.

[^11]: Sensitivity refers to the minimum number of copies detected after serial ten-fold dilutions of DNA plasmid, in all triplicates. All three replicates must have a detectable Ct value for inclusion.

[^12]: Copy number is equivalent to 0.0001 pg DNA plasmid standard.

[^13]: Copy number is equivalent to 0.00001 pg DNA plasmid standard.

[^14]: Plasmid did not overlap with previously published primer sequence.

[^15]: No change in expression compared to unstimulated cells.

[^16]: Upregulation in expression compared to unstimulated cells.

[^17]: Down-regulation in expression compared to unstimulated cells.

[^18]: Significant change \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001.

[^19]: Not detected.
